Testing reveals transfusing young blood into Alzheimer's patients does not reverse disease

November 3, 2017 by Bob Yirka, Medical Xpress report
Credit: public domain

(Medical Xpress)—A team of researchers with a startup company called Alkahest will be giving a presentation at this year's Clinical Trials on Alzheimer's Disease Conference detailing results of testing blood transfusions on elderly Alzheimer's patients. They are expected to claim that their testing revealed both null and positive results.

Representatives for Alkahest have been very vocal about their research efforts—the goal of the company is to find out if transfusing blood from young people into Alzheimer's patients will slow, stop or even reverse the symptoms of the disease.

The initiative by Alkahest is part of a broader program by and others less qualified to determine if transfusing the blood of young, healthy people into older people, or people who are sick, offers any benefits. The whole grand experiment got its start a century and a half ago, when scientists sutured a young mouse to an old mouse to see if the old mouse would become younger. While that early research did report some benefits for the older mouse, the technique was not pursued for another hundred years. In more recent times, researchers have tried repeating the same experiments, while others have tried infusing blood and some have tried infusing just plasma. Such experiments have met thus far with mixed results, though most agree that young blood can rejuvenate body parts in some .

In this new experiment, the researchers found 16 people with Alzheimer's disease who were willing to participate in the experimental program. Some were given young , while others were given a placebo. After a certain amount of time, the patients were switched so that all could receive the at some point in the experiment.

The researchers report that none of the volunteers did any better on cognitive tests taken during or after the conclusion of the transfusions. But, they note, that tests given to the people who took care of the patients revealed that virtually all of the volunteers did better at real life tasks, like getting dressed and helping with shopping. Others not involved with the study have suggested that such changes in ability are most likely due to an increase in attention by their caretakers, rather than from any benefit of the transfusions.

Explore further: Aging mice given blood plasma from young humans regain youthful attributes

More information: The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study (PLASMA), clinicaltrials.gov/ct2/show/NCT02256306

Related Stories

Aging mice given blood plasma from young humans regain youthful attributes

November 17, 2016
(Medical Xpress)—A team of researchers working at a company called Alkahest has reported at this year's Society for Neuroscience annual meeting that injections of blood plasma from young human beings caused aging mice to ...

Research group finds blood transfusions from young mice to old improves brain function

October 19, 2012
(Medical Xpress)—A research team from Stanford University has found that injecting the blood of young mice into older mice can cause new neural development and improved memory. Team lead Saul Villeda presented the groups' ...

Positive results from Alzheimer's drug in Phase 1 clinical trial extension

November 3, 2017
The pharmaceutical company Biogen has today announced the results of an extended phase 1b clinical trial of the potential Alzheimer's disease drug, aducanumab. Results from the extended early stage trial, were announced today ...

Is older blood OK to use in a transfusion?

September 27, 2017
(HealthDay)—Using older red blood cells to give transfusions to critically ill patients doesn't appear to affect their risk of dying, Australian researchers report.

Does improving cardiovascular health reduce risk of dementia?

September 12, 2017
Researchers at Washington University School of Medicine in St. Louis are recruiting volunteers for a national study that is exploring whether strategies to improve cardiovascular health also reduce the risk of dementia in ...

Understanding Alzheimer's disease and Down syndrome

July 26, 2017
People who have Down syndrome may develop Alzheimer's disease at a younger age than people without Down syndrome. Recently, however, research showed that some people with Down syndrome might not develop dementia at all. Doctors ...

Recommended for you

Discovery could explain failed clinical trials for Alzheimer's, and provide a solution

September 19, 2018
Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trials have failed. The study also identifies a clinically ...

Machine learning IDs markers to help predict Alzheimer's

September 19, 2018
Nearly 50 million people worldwide have Alzheimer's disease or another form of dementia. These irreversible brain disorders slowly cause memory loss and destroy thinking skills, eventually to such an extent that self-care ...

Air pollution may be linked to heightened dementia risk

September 18, 2018
Air pollution may be linked to a heightened risk of developing dementia, finds a London-based observational study, published in the online journal BMJ Open. The associations found couldn't be explained by factors known to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

Study prevents cognitive decline in older blacks with memory loss

September 10, 2018
With nearly twice the rate of dementia as whites, blacks are at a higher risk for developing diseases like Alzheimer's, but there has been little research on how to reduce this racial health disparity. A new study in black ...

Excessive daytime sleepiness linked with brain protein involved in Alzheimer's disease

September 6, 2018
Analysis of data captured during a long-term study of aging adults shows that those who report being very sleepy during the day were nearly three times more likely than those who didn't to have brain deposits of beta amyloid, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Nov 03, 2017
These were not given whole blood. They were given plasma. The results are therefore not indicative of what would happen if the test were of whole blood.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.